Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players)

    Published: April 1, 2009 | Price: $995.00 – $7,000.00

    Pharmacodiagnostics are considered the pathway to what has been termed "personalized medicine," the use of molecular analysis to achieve optimum medical outcomes in the management of a patient’s disease or predisposition to disease. As such, personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this undertaking? What are the likely challenges for pharma companies and...
    Physician Office In Vitro Diagnostic (IVD) Test Markets

    Published: January 9, 2023 | Price: $5,000.00 – $10,000.00

    This report analyzes trends in global demand for in vitro diagnostic (IVD) products used in physicians’ office laboratories. Specific products consist of reagents, test kits, standards and controls, and instruments and systems based on immunoassay, clinical chemistry, hematology, molecular, microbiology, and coagulation technologies.  Physicians’ office laboratories are defined as point-of-care (POC) testing sites within traditional practices or urgent care centers staffed by one or more physicians. Most of these laboratories implement IVD procedures through one or more portable desktop instruments...
    Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests)

    Published: August 15, 2014 | Price: $3,995.00 – $7,990.00

    Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests) Physician office laboratories are a diverse but significant market for IVD products. The range of POLs is vast: Individual physicians may peform in-office pregnancy and glucose tests, run automated CBCs and chemistry panels or perform moderate complexity infectious disease tests using plate immunoassays and molecular assays. This report, Physician Office Laboratory Markets is...
    Physician Office Laboratory (POL) Testing Markets Worldwide – Status Quo and Future Trends

    Published: May 1, 2007 | Price: $2,995.00 – $5,990.00

    Many in the clinical and manufacturing community have their eyes on the Physician Office Laboratory (POL) as an outlet both to improve patient compliance and outcomes and to open new market opportunities. Studies are emerging on the clinical outcomes and cost-benefit of nearer-the-patient testing, but little certain is known about POLs as a distribution channel for diagnostics products. Kalorama's Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends takes a bold look into the technologies and trends...
    Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends

    Published: November 1, 2010 | Price: $1,995.00 – $3,990.00

    Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends The physician office laboratory (POL) is usually not broken out in market research reports covering the medical device and diagnostic industry. Numbers are often simply grouped in with hospital and service lab sales. But for marketing strategy, knowing where diagnostic tests occur is as important as the revenue numbers. Now, Kalorama Information shines further light onto the POL testing market with its report, Physician office Laboratory (POL) Testing...
    POC Cholesterol Testing Market

    Published: January 26, 2016 | Price: $796.00 – $1,592.00

    Point of Care (POC) Cholesterol Testing Market Point of Care (POC) Cholesterol Testing Market presents the revenue picture for cholesterol testing performed at or near the site where the patient is located. The following data regarding the POC cholesterol market are provided: world POC cholesterol testing revenue estimates, 2012-2020; POC cholesterol self-testing revenue estimates, 2015 and 2020; POC cholesterol professional testing revenue estimates, 2015 and 2020; world POC cholesterol testing revenue estimates and market share of leading manufacturers, 2014; and...
    POC Pregnancy and Fertility Testing Market

    Published: December 29, 2015 | Price: $696.50 – $1,393.00

    Point of Care (POC) Pregnancy and Fertility Testing Market The female reproductive system is complex both in structure and in function. From birth to senescence, the organs of the female reproductive system function in concert with each other, with the brain, and with other endocrine organs. This integrated functioning constitutes some of the most intricate and elegant processes of the human body. Because the functioning of the female reproductive system has an enormous impact on the life of the individual...
    POC Urinalysis Testing Market: Forecasts to 2019

    Published: December 17, 2015 | Price: $349.30 – $700.00

    Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market examines the urine strip segment of the global POC professional testing and self-testing markets and the urinalysis segment of the POC professional drugs of abuse testing market, including: Selected Dipstick Urinalysis Systems, 2014 Global POC Urine Strip Testing Market Analysis: 2012-2019 POC Urine Strip Self-Testing Market Analysis, 2014 and 2019 POC Urine...
    Point of Care (POC) Infectious Disease Diagnostic Testing Market

    Published: March 22, 2018 | Price: $2,995.00 – $5,995.00

    This Kalorama Information report, Point of Care Infectious Disease Diagnostic Testing provides market sizing and forecasts for the following disease areas Influenza STD HIV Hepatitis Malaria C. difficile E. coli H. pylori Home Test/OTC Others Point of care testing market features competitors that are large major concerns as well as newer entrants and specialist players.  As part of its coverage, the report also profiles competitors in the market, including the following: Abbott/Alere Atlas Genetics Ltd. Atlas Link Biotech Co., Ltd...
    Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads

    Published: November 1, 2009 | Price: $3,995.00 – $7,990.00

    As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? Kalorama believes that the drive for wellness and the attention surrounding healthcare reform will focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to be fully utilized, and those companies willing to pivot...
    Point of Care Diagnostics for Emerging Infectious Disease Threats (Dengue Fever, HIV, HPV, STDs, Chagas, TB, and Other IDs): Market Analysis and Technical Considerations

    Published: October 1, 2011 | Price: $150.00 – $300.00

    The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with the fastest growth, and...
    Point of Care Diagnostics Market in Retail Clinics (Cholesterol, Diabetes, Influenza, Other Tests)

    Published: March 28, 2018 | Price: $1,500.00 – $3,000.00

    Convenience clinics are designed to occupy small spaces and provide just basic care. Therefore, they do not use most of the sophisticated medical equipment found in hospitals or specialty centers such as advanced imaging devices. In fact, while a few larger centers have x-ray machines, most do not. However, retail clinics are becoming relatively large users of point-of-care (POC) tests, clinical chemistry and immunoassay laboratory tests and vaccines. This chapter examines the effect of retail clinics on each of these...
    Point-of-Care Glucose Monitoring Market: World Market Analysis

    Published: March 21, 2018 | Price: $1,500.00 – $3,000.00

    This report provides market estimates and forecasts for point-of-care glucose testing.  Information in this report is from the latest published figures for companies participating in the market as well as recent interviews.  The following markets analysis is provided in this report:  Global POC Glucose Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)   POC Blood Glucose Testing Regional Market Analysis, 2017 (US, Europe, Asia, ROW)   Global POC Glucose Self-Testing Market (includes continuous glucose devices)  ...
    Potential “Pipeline Disruptors” – New Products That Will Drive The Future Pharmaceutical Market

    Published: May 15, 2017 | Price: $3,360.00 – $6,720.00

    Potential Pipeline Disruptors: Innovative Pharmaceuticals in Alzheimer's Disease, Asthma and Cancer This report covers market opportunities based on pipeline developments for six key therapeutic specialities: Alzheimer's Disease Asthma Breast Cancer Leukemia Lung Cancer Lymphoma These six areas are expected to show the strongest pipeline impact and candidates are likely to replace current therapies. The market is evaluated for 2015 and 2016 with forecast data provided through 2022. Forecast data were derived from a combination of pipeline analyses, current product treatment...
    Precision Cancer Therapeutics Market, 2022

    Published: October 25, 2022 | Price: $5,000.00 – $10,000.00

    Despite advances in cancer treatment, cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry.  Worldwide between 35 and 40 million people are living with cancer and nearly 10 million people lose the battle annually.  The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. Cancer deaths occur in about 50% of people who develop cancer in...